These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 30709064)

  • 21. Modified Colistin Regimen for Critically Ill Patients with Acute Renal Impairment and Continuous Renal Replacement Therapy.
    Menna P; Salvatorelli E; Mattei A; Cappiello D; Minotti G; Carassiti M
    Chemotherapy; 2018; 63(1):35-38. PubMed ID: 29334366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Colistin Population Pharmacokinetics after Application of a Loading Dose of 9 MU Colistin Methanesulfonate in Critically Ill Patients.
    Karaiskos I; Friberg LE; Pontikis K; Ioannidis K; Tsagkari V; Galani L; Kostakou E; Baziaka F; Paskalis C; Koutsoukou A; Giamarellou H
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7240-8. PubMed ID: 26369974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emergent renal dysfunction with colistin pharmacotherapy.
    Collins JM; Haynes K; Gallagher JC
    Pharmacotherapy; 2013 Aug; 33(8):812-6. PubMed ID: 23606349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-dose, extended-interval colistin administration in critically ill patients: is this the right dosing strategy? A preliminary study.
    Dalfino L; Puntillo F; Mosca A; Monno R; Spada ML; Coppolecchia S; Miragliotta G; Bruno F; Brienza N
    Clin Infect Dis; 2012 Jun; 54(12):1720-6. PubMed ID: 22423120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colistin treatment in patients with ICU-acquired infections caused by multiresistant Gram-negative bacteria: the renaissance of an old antibiotic.
    Michalopoulos AS; Tsiodras S; Rellos K; Mentzelopoulos S; Falagas ME
    Clin Microbiol Infect; 2005 Feb; 11(2):115-21. PubMed ID: 15679485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous colistin for multidrug-resistant gram-negative infections in critically ill pediatric patients.
    Kapoor K; Jajoo M; Dublish S; Dabas V; Gupta S; Manchanda V
    Pediatr Crit Care Med; 2013 Jul; 14(6):e268-72. PubMed ID: 23689704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
    Nazer LH; Rihani S; Hawari FI; Le J
    Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for acute kidney injury in critically ill patients with bacteraemia by carbapenem non-susceptible Gram negative bacteria.
    Papadimitriou-Olivgeris M; Assimakopoulos SF; Kolonitsiou F; Solomou A; Vamvakopoulou S; Spyropoulou A; Karamouzos V; Anastassiou ED; Papachristou E; Spiliopoulou I; Christofidou M; Fligou F; Marangos M
    Infez Med; 2019 Dec; 27(4):380-392. PubMed ID: 31846987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravenous colistimethate (colistin) use in critically ill children without cystic fibrosis.
    Falagas ME; Sideri G; Vouloumanou EK; Papadatos JH; Kafetzis DA
    Pediatr Infect Dis J; 2009 Feb; 28(2):123-7. PubMed ID: 19116601
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous colistin use for infections due to MDR Gram-negative bacilli in critically ill paediatric patients: a systematic review and meta-analysis.
    Karageorgos SA; Bassiri H; Siakallis G; Miligkos M; Tsioutis C
    J Antimicrob Chemother; 2019 Sep; 74(9):2497-2506. PubMed ID: 31049586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association between colistin dose and microbiologic outcomes in patients with multidrug-resistant gram-negative bacteremia.
    Vicari G; Bauer SR; Neuner EA; Lam SW
    Clin Infect Dis; 2013 Feb; 56(3):398-404. PubMed ID: 23090926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
    Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
    Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Colistin nephrotoxicity in critically ill patients after implementation of a new dosing strategy.
    Ozel AS; Ergönül Ö; Korten V
    J Infect Dev Ctries; 2019 Oct; 13(10):877-885. PubMed ID: 32084017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.
    Rocco M; Montini L; Alessandri E; Venditti M; Laderchi A; De Pascale G; Raponi G; Vitale M; Pietropaoli P; Antonelli M
    Crit Care; 2013 Aug; 17(4):R174. PubMed ID: 23945197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Population Pharmacokinetics of Colistin Methanesulfonate and Colistin in Critically Ill Patients with Acute Renal Failure Requiring Intermittent Hemodialysis.
    Jacobs M; Grégoire N; Mégarbane B; Gobin P; Balayn D; Marchand S; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2016 Jan; 60(3):1788-93. PubMed ID: 26729492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical assessment of colistin in treating infections caused by multidrug-resistant gram-negative bacillus in patients with severe burn].
    Zhang JP; Yang XS; Chen J; Peng YZ; Huang YS
    Zhonghua Shao Shang Za Zhi; 2009 Oct; 25(5):372-6. PubMed ID: 19951562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience of colistin-glycopeptide combination in critically ill patients infected with Gram-negative bacteria.
    Petrosillo N; Giannella M; Antonelli M; Antonini M; Barsic B; Belancic L; Inkaya A C; De Pascale G; Grilli E; Tumbarello M; Akova M
    Antimicrob Agents Chemother; 2014; 58(2):851-8. PubMed ID: 24277037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
    Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
    Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colistin Use in Patients With Reduced Kidney Function.
    Fiaccadori E; Antonucci E; Morabito S; d'Avolio A; Maggiore U; Regolisti G
    Am J Kidney Dis; 2016 Aug; 68(2):296-306. PubMed ID: 27160031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Colistin nephrotoxicity in the ICU: Is it different in the geriatric patients?
    Aydoğan BB; Yıldırım F; Zerman A; Gönderen K; Türkoğlu M; Aygencel G
    Aging Clin Exp Res; 2018 Jun; 30(6):573-580. PubMed ID: 28866836
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.